Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : STC-004
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : National Institute on Drug Abuse
Deal Size : $15.0 million
Deal Type : Funding
Details : The funding will be used for the development of SiteOne's selective NaV1.8 inhibitor, STC-004, an investigational, non-opioid treatment for acute and chronic pain conditions.
Brand Name : STC-004
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 18, 2023
Lead Product(s) : STC-004
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : National Institute on Drug Abuse
Deal Size : $15.0 million
Deal Type : Funding
Lead Product(s) : ST-2427
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Vertex Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of the agreement, the companies will work together to advance potent and selective inhibitors of sodium ion channel 1.7 (NaV1.7) as non-opioid therapeutics for the treatment of pain.
Brand Name : ST-2427
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 19, 2022
Lead Product(s) : ST-2427
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Vertex Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Preclinical
Sponsor : National Institutes of Health
Deal Size : $1.7 million
Deal Type : Funding
SiteOne Therapeutics Announces $1.73M Grant from NIH/NHLBI and Adds Respiratory Advisory Team
Details : Funding will support the development of an inhaled formulation of SiteOne’s drug candidate for chronic cough through IND-enabling studies and toward the clinic.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 11, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Preclinical
Sponsor : National Institutes of Health
Deal Size : $1.7 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?